Global Medication Management Market Overview

The Medication Management Market Size is expected to grow from USD 5.23 billion in 2023 to USD 11.45 billion by 2032, at a CAGR of 9.1% during the forecast period (2024-2032).

The Medication Management market encompasses a broad array of systems and services designed to ensure the safe and effective administration of medications to patients. This market includes electronic health records (EHRs), computerized physician order entry (CPOE) systems, clinical decision support systems (CDSS), medication administration records (MARs), automated dispensing systems, and pharmacy information systems. The primary goal is to minimize medication errors, enhance patient safety, and improve overall healthcare outcomes.

As of 2024, the market is experiencing robust growth driven by several key factors. The increasing prevalence of chronic diseases, the aging global population, and the subsequent rise in the volume of medications prescribed are significant contributors. Technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML) in medication management systems, have further propelled the market. These technologies enable more precise and personalized medication regimens, predictive analytics for potential adverse drug events, and enhanced operational efficiencies for healthcare providers.

Regulatory frameworks and government initiatives aimed at improving healthcare quality and patient safety are also driving market expansion. For instance, mandates for electronic prescribing and the implementation of health IT infrastructure in various regions have spurred the adoption of advanced medication management solutions. The COVID-19 pandemic has underscored the importance of digital health solutions, leading to accelerated adoption and innovation in this sector.

Geographically, North America dominates the market due to advanced healthcare infrastructure, high adoption rates of technology, and supportive government policies. Europe and Asia-Pacific are also significant markets, with the latter showing the fastest growth due to expanding healthcare infrastructure and increasing investments in digital health.

Market Dynamics And Factors For Medication Management Market

Driver:

Minimum Cost Required For Medication Management

Medication management provides cost-effective care. Patients can save money by only buying medication determined to be appropriate and most effective. They can achieve additional saving via declining adverse events and improved adherence to a regimen, which requires additional treatment. By decreasing the hospital admissions, emergency department visits, and wasted time on unproductive regimen assessment, and adjustment. These factors involve the growth of the medication management market. Errors in the medication cause dangerous problems or sometimes need for medical emergency and patients require more medical treatment or hospitalization, and it becomes costly. For instance, according to Statista 42 million US dollars is the medication error costs annually worldwide. This can be avoided by properly managing medications and the minimum cost required for this, which helps to increase the market of medication management in the projected timeframe.

Restraint:

Lack of Awareness Regards the Medication Management

Most peoples in developing countries are less aware of medication management which hinders the market growth of medication management. Because of the rising prevalence of diseases, they take multiple medicines which cause adverse reactions due to the mixing of medication with supplements or foods. Medication management creates the treatment plan and also monitors the side effects associated with medicines. But peoples are not more aware of the benefits of medication management which hamper the growth of the market.

Opportunity:

Growing Number of Hospitals Investing in New Technology

Due to the rising prevalence of diseases, hospitals, and other healthcare centers increasing their investment in the new technology to improve the management service of healthcare, and avoid medication errors. This is a lucrative opportunity for the market of medication management. For instance, according to Statista, in 2020 investors 21 billion US dollars were invested in the digital health industry. Medication management offers remote medical care, and telemedicine service, this also provides a gainful opportunity for the market of medication management.

Segmentation Analysis Of Medication Management Market

By type, the CDSS segment is projected to have the maximum share of the medication management market during the projected timeframe. CDSS means clinical decision support system which offers the care, diagnosis, or therapy containing medications for the treatment of diseases. CDSS related to the medication system which supports decisions related to medication including processes such as prescribing, administration, and monitoring for effectiveness and adverse effects. CDDS has multiple functions such as computerized alerts and reminders to caregivers and patients, clinical guidelines, focused patient data reports and summaries, diagnostic support, and documentation templates. These factors are anticipated to increase the growth of the medication management market in the forecast period.

By delivery mode, the cloud-based segment is expected to lead the development of the medication management market in the forecast year. Rising the prevalence of patient support to increase the healthcare sectors. There is a need for storage, and maintaining patient-related data such as medication history, and disease-related history. It makes it easy for physicians to give the treatment to patients on the basis of their history of patients. For this purpose, cloud platforms are adopted by various healthcare. Cloud-based platforms are cost-effective and have the capability to store excess data. These factors involve the growth of the market in the projected timeframe.

By end-users, the hospital segment is anticipated to dominate the medication management market in the analysis timespan. The growing prevalence of disease increases the patient visits to hospitals which contain some patients are in-patients and some are out-patients. So, to give better care to patients most hospitals increase the investment in the purchase and development of their IT systems. It helps to enhance workflow efficiency by dispensing medication safely and simplifying complex clinical processes. These factors supported market growth over the forecast year.

Regional Analysis Of Medication Management Market

The North American region is projected to the development of the medication management market over the forecasted year owing to the significant adoption of IT in healthcare, as well as advancement in technology, growth in the incidence of infectious and chronic diseases, and an increase in the number of prescriptions. The CDC evaluates that six adults out of ten in the US region live with chronic diseases and 38% of death accounted for cancer only. Thus, the US region is projected to largest medication management system in the North American region. Rising the awareness regards the new technology and the presence of a huge number of small and medium-scale players that provide the medication management service which boosts the market of medication management in this region in the analysis timespan.

The Europe region second dominated the medication management market in the projected period. Several players in this region are engaged in the development of cloud-based deployment solutions that can provide easy information support to the medication management system. In the Europe region, Germany dominates the market for medication management. Rising the burden of chronic and infectious diseases, the number of prescriptions dispensed by pharmacists. Thus, to overcome the workload on pharmacists rising the use of Automated Solutions in pharmacies facilitated the growth of the medication management market in this region. In addition to this, the rising aging population is also affecting the market growth. For instance, Statista stated that Italy in the Europe region has the largest market share in the elderly population about 23.5% of 65 years or older people live in this country. The growing demand for declining healthcare costs, technological development, and an increase in the demand for remote patient monitoring services, these factors also involved in the growth of the market in the forecast period.

In the Asia Pacific, the growing incidence of chronic diseases and the rising aging population support the growth of the market. For instance, according to Statista, in 2020 huge portion of people in China suffering from chronic diseases. 500 million peoples were overweight or obese and 400 million people were affected by blood pressure-related diseases. The growing number of healthcare sectors with increased the rate of adoption of IT technology for the management of diseases, rising the demand a for computerized physicians for the treatment of disease, the number of prescriptions increases, and high investment in purchasing new software for the management of disease by hospitals as well as government, these all factors support the growth of the market in the projection timeframe.

Top Key Players Covered In Medication Management Market

• Omnicell (USA)
• Cerner Corporation (USA)
• McKesson Corporation (USA)
• BD (Becton, Dickinson and Company) (USA)
• Swisslog Healthcare (Switzerland)
• Parata Systems (USA)
• ScriptPro (USA)
• Capsa Healthcare (USA)
• MedMinder Systems (USA)
• Talyst (USA)
• CareFusion (USA)
• Aethon (USA)
• Tabula Rasa HealthCare (USA)
• Pharmacy Automation Supplies (USA)
• Health Care Logistics (USA)
• GSL Solutions (USA)
• RxSafe (USA)
• Mediware Information Systems (USA)
• CarePredict (USA)
• PillPack (USA)

Key Industry Development In The Medication Management Market

• In April 2024, Health technology pioneer DrFirst and PatchRx, a medication adherence company, announced a partnership to close the gap between a healthcare provider’s recommended medication therapy and the patient’s actual medicine-taking behavior.  This collaboration aims to mitigate the health and economic impacts of medication non-adherence, which is linked to approximately 125,000 deaths and nearly $250 billion in healthcare costs annually in the U.S. By combining prescription fill data and remote monitoring data.
• In April 2024, Healthcare technology pioneer DrFirst announced it had acquired substantially all assets of Myndshft Technologies, Inc., a leader of end-to-end real-time medical benefits and automated prior authorization (PA) software-as-a-service (SaaS). This strategic acquisition aims to improve the patient experience and expedite access to vital specialty medications, such as infusions and in-office injectables primarily covered by medical benefits. Combined with DrFirst’s platform and scale, the technology will also lighten the substantial administrative load on healthcare providers and their staff.
• In April 2023, North Dakota Governor Doug Burgum signed new legislation into law that requires health insurance companies to include comprehensive medication management (CMM) services in commercial health benefit plans. The law ensures that citizens in North Dakota will have access to coordinated, consistent, comprehensive services that optimize medication use. Its passage was supported by the Get the Medications Right Institute, a coalition of more than 1,700 stakeholders representing over 1000 companies across the employer and health care spectrum who support greater adoption of CMM.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Delivery Mode
 3.3 By End Users

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Medication Management Market by Type
 5.1 Medication Management Market Overview Snapshot and Growth Engine
 5.2 Medication Management Market Overview
 5.3 Computerized provider order entry (CPOE)
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Computerized provider order entry (CPOE): Grographic Segmentation
 5.4 Clinical decision support systems (CDSS)
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Clinical decision support systems (CDSS): Grographic Segmentation
 5.5 Electronic Medication Administration Record
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Electronic Medication Administration Record: Grographic Segmentation
 5.6 Automated Dispensing
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Automated Dispensing: Grographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Grographic Segmentation

Chapter 6: Medication Management Market by Delivery Mode
 6.1 Medication Management Market Overview Snapshot and Growth Engine
 6.2 Medication Management Market Overview
 6.3 On-premise
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 On-premise: Grographic Segmentation
 6.4 Cloud-based
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Cloud-based: Grographic Segmentation

Chapter 7: Medication Management Market by End Users
 7.1 Medication Management Market Overview Snapshot and Growth Engine
 7.2 Medication Management Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Grographic Segmentation
 7.4 Pharmacies
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Pharmacies: Grographic Segmentation
 7.5 Others
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Medication Management Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Medication Management Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Medication Management Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 ALLSCRIPTS HEALTHCARE SOLUTIONS INC
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 GE HEALTHCARE (GE COMPANY)
 8.4 TALYST
 8.5 LLC (PSYCHIATRIC SOLUTIONS INC.)
 8.6 ARXIUM
 8.7 CERNER CORPORATION
 8.8 OMNICELL INC.
 8.9 BECTON
 8.10 DICKINSON AND COMPANY
 8.11 QUADRAMED AFFINITY CORPORATION
 8.12 MCKESSON CORPORATION
 8.13 SIEMENS LTD.
 8.14 OTHER MAJOR PLAYERS

Chapter 9: Global Medication Management Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Computerized provider order entry (CPOE)
  9.2.2 Clinical decision support systems (CDSS)
  9.2.3 Electronic Medication Administration Record
  9.2.4 Automated Dispensing
  9.2.5 Others
 9.3 Historic and Forecasted Market Size By Delivery Mode
  9.3.1 On-premise
  9.3.2 Cloud-based
 9.4 Historic and Forecasted Market Size By End Users
  9.4.1 Hospitals
  9.4.2 Pharmacies
  9.4.3 Others

Chapter 10: North America Medication Management Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Computerized provider order entry (CPOE)
  10.4.2 Clinical decision support systems (CDSS)
  10.4.3 Electronic Medication Administration Record
  10.4.4 Automated Dispensing
  10.4.5 Others
 10.5 Historic and Forecasted Market Size By Delivery Mode
  10.5.1 On-premise
  10.5.2 Cloud-based
 10.6 Historic and Forecasted Market Size By End Users
  10.6.1 Hospitals
  10.6.2 Pharmacies
  10.6.3 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Medication Management Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Computerized provider order entry (CPOE)
  11.4.2 Clinical decision support systems (CDSS)
  11.4.3 Electronic Medication Administration Record
  11.4.4 Automated Dispensing
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By Delivery Mode
  11.5.1 On-premise
  11.5.2 Cloud-based
 11.6 Historic and Forecasted Market Size By End Users
  11.6.1 Hospitals
  11.6.2 Pharmacies
  11.6.3 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Medication Management Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Computerized provider order entry (CPOE)
  12.4.2 Clinical decision support systems (CDSS)
  12.4.3 Electronic Medication Administration Record
  12.4.4 Automated Dispensing
  12.4.5 Others
 12.5 Historic and Forecasted Market Size By Delivery Mode
  12.5.1 On-premise
  12.5.2 Cloud-based
 12.6 Historic and Forecasted Market Size By End Users
  12.6.1 Hospitals
  12.6.2 Pharmacies
  12.6.3 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Medication Management Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Computerized provider order entry (CPOE)
  13.4.2 Clinical decision support systems (CDSS)
  13.4.3 Electronic Medication Administration Record
  13.4.4 Automated Dispensing
  13.4.5 Others
 13.5 Historic and Forecasted Market Size By Delivery Mode
  13.5.1 On-premise
  13.5.2 Cloud-based
 13.6 Historic and Forecasted Market Size By End Users
  13.6.1 Hospitals
  13.6.2 Pharmacies
  13.6.3 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Medication Management Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Computerized provider order entry (CPOE)
  14.4.2 Clinical decision support systems (CDSS)
  14.4.3 Electronic Medication Administration Record
  14.4.4 Automated Dispensing
  14.4.5 Others
 14.5 Historic and Forecasted Market Size By Delivery Mode
  14.5.1 On-premise
  14.5.2 Cloud-based
 14.6 Historic and Forecasted Market Size By End Users
  14.6.1 Hospitals
  14.6.2 Pharmacies
  14.6.3 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. MEDICATION MANAGEMENT MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. MEDICATION MANAGEMENT MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. MEDICATION MANAGEMENT MARKET COMPETITIVE RIVALRY
TABLE 005. MEDICATION MANAGEMENT MARKET THREAT OF NEW ENTRANTS
TABLE 006. MEDICATION MANAGEMENT MARKET THREAT OF SUBSTITUTES
TABLE 007. MEDICATION MANAGEMENT MARKET BY TYPE
TABLE 008. COMPUTERIZED PROVIDER ORDER ENTRY (CPOE) MARKET OVERVIEW (2016-2028)
TABLE 009. CLINICAL DECISION SUPPORT SYSTEMS (CDSS) MARKET OVERVIEW (2016-2028)
TABLE 010. ELECTRONIC MEDICATION ADMINISTRATION RECORD MARKET OVERVIEW (2016-2028)
TABLE 011. AUTOMATED DISPENSING MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. MEDICATION MANAGEMENT MARKET BY DELIVERY MODE
TABLE 014. ON-PREMISE MARKET OVERVIEW (2016-2028)
TABLE 015. CLOUD-BASED MARKET OVERVIEW (2016-2028)
TABLE 016. MEDICATION MANAGEMENT MARKET BY END USERS
TABLE 017. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 018. PHARMACIES MARKET OVERVIEW (2016-2028)
TABLE 019. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 020. NORTH AMERICA MEDICATION MANAGEMENT MARKET, BY TYPE (2016-2028)
TABLE 021. NORTH AMERICA MEDICATION MANAGEMENT MARKET, BY DELIVERY MODE (2016-2028)
TABLE 022. NORTH AMERICA MEDICATION MANAGEMENT MARKET, BY END USERS (2016-2028)
TABLE 023. N MEDICATION MANAGEMENT MARKET, BY COUNTRY (2016-2028)
TABLE 024. EUROPE MEDICATION MANAGEMENT MARKET, BY TYPE (2016-2028)
TABLE 025. EUROPE MEDICATION MANAGEMENT MARKET, BY DELIVERY MODE (2016-2028)
TABLE 026. EUROPE MEDICATION MANAGEMENT MARKET, BY END USERS (2016-2028)
TABLE 027. MEDICATION MANAGEMENT MARKET, BY COUNTRY (2016-2028)
TABLE 028. ASIA PACIFIC MEDICATION MANAGEMENT MARKET, BY TYPE (2016-2028)
TABLE 029. ASIA PACIFIC MEDICATION MANAGEMENT MARKET, BY DELIVERY MODE (2016-2028)
TABLE 030. ASIA PACIFIC MEDICATION MANAGEMENT MARKET, BY END USERS (2016-2028)
TABLE 031. MEDICATION MANAGEMENT MARKET, BY COUNTRY (2016-2028)
TABLE 032. MIDDLE EAST & AFRICA MEDICATION MANAGEMENT MARKET, BY TYPE (2016-2028)
TABLE 033. MIDDLE EAST & AFRICA MEDICATION MANAGEMENT MARKET, BY DELIVERY MODE (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA MEDICATION MANAGEMENT MARKET, BY END USERS (2016-2028)
TABLE 035. MEDICATION MANAGEMENT MARKET, BY COUNTRY (2016-2028)
TABLE 036. SOUTH AMERICA MEDICATION MANAGEMENT MARKET, BY TYPE (2016-2028)
TABLE 037. SOUTH AMERICA MEDICATION MANAGEMENT MARKET, BY DELIVERY MODE (2016-2028)
TABLE 038. SOUTH AMERICA MEDICATION MANAGEMENT MARKET, BY END USERS (2016-2028)
TABLE 039. MEDICATION MANAGEMENT MARKET, BY COUNTRY (2016-2028)
TABLE 040. ALLSCRIPTS HEALTHCARE SOLUTIONS INC: SNAPSHOT
TABLE 041. ALLSCRIPTS HEALTHCARE SOLUTIONS INC: BUSINESS PERFORMANCE
TABLE 042. ALLSCRIPTS HEALTHCARE SOLUTIONS INC: PRODUCT PORTFOLIO
TABLE 043. ALLSCRIPTS HEALTHCARE SOLUTIONS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. GE HEALTHCARE (GE COMPANY): SNAPSHOT
TABLE 044. GE HEALTHCARE (GE COMPANY): BUSINESS PERFORMANCE
TABLE 045. GE HEALTHCARE (GE COMPANY): PRODUCT PORTFOLIO
TABLE 046. GE HEALTHCARE (GE COMPANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. TALYST: SNAPSHOT
TABLE 047. TALYST: BUSINESS PERFORMANCE
TABLE 048. TALYST: PRODUCT PORTFOLIO
TABLE 049. TALYST: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. LLC (PSYCHIATRIC SOLUTIONS INC.): SNAPSHOT
TABLE 050. LLC (PSYCHIATRIC SOLUTIONS INC.): BUSINESS PERFORMANCE
TABLE 051. LLC (PSYCHIATRIC SOLUTIONS INC.): PRODUCT PORTFOLIO
TABLE 052. LLC (PSYCHIATRIC SOLUTIONS INC.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. ARXIUM: SNAPSHOT
TABLE 053. ARXIUM: BUSINESS PERFORMANCE
TABLE 054. ARXIUM: PRODUCT PORTFOLIO
TABLE 055. ARXIUM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. CERNER CORPORATION: SNAPSHOT
TABLE 056. CERNER CORPORATION: BUSINESS PERFORMANCE
TABLE 057. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 058. CERNER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. OMNICELL INC.: SNAPSHOT
TABLE 059. OMNICELL INC.: BUSINESS PERFORMANCE
TABLE 060. OMNICELL INC.: PRODUCT PORTFOLIO
TABLE 061. OMNICELL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. BECTON: SNAPSHOT
TABLE 062. BECTON: BUSINESS PERFORMANCE
TABLE 063. BECTON: PRODUCT PORTFOLIO
TABLE 064. BECTON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. DICKINSON AND COMPANY: SNAPSHOT
TABLE 065. DICKINSON AND COMPANY: BUSINESS PERFORMANCE
TABLE 066. DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 067. DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. QUADRAMED AFFINITY CORPORATION: SNAPSHOT
TABLE 068. QUADRAMED AFFINITY CORPORATION: BUSINESS PERFORMANCE
TABLE 069. QUADRAMED AFFINITY CORPORATION: PRODUCT PORTFOLIO
TABLE 070. QUADRAMED AFFINITY CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. MCKESSON CORPORATION: SNAPSHOT
TABLE 071. MCKESSON CORPORATION: BUSINESS PERFORMANCE
TABLE 072. MCKESSON CORPORATION: PRODUCT PORTFOLIO
TABLE 073. MCKESSON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. SIEMENS LTD.: SNAPSHOT
TABLE 074. SIEMENS LTD.: BUSINESS PERFORMANCE
TABLE 075. SIEMENS LTD.: PRODUCT PORTFOLIO
TABLE 076. SIEMENS LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 077. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 078. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 079. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. MEDICATION MANAGEMENT MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. MEDICATION MANAGEMENT MARKET OVERVIEW BY TYPE
FIGURE 012. COMPUTERIZED PROVIDER ORDER ENTRY (CPOE) MARKET OVERVIEW (2016-2028)
FIGURE 013. CLINICAL DECISION SUPPORT SYSTEMS (CDSS) MARKET OVERVIEW (2016-2028)
FIGURE 014. ELECTRONIC MEDICATION ADMINISTRATION RECORD MARKET OVERVIEW (2016-2028)
FIGURE 015. AUTOMATED DISPENSING MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. MEDICATION MANAGEMENT MARKET OVERVIEW BY DELIVERY MODE
FIGURE 018. ON-PREMISE MARKET OVERVIEW (2016-2028)
FIGURE 019. CLOUD-BASED MARKET OVERVIEW (2016-2028)
FIGURE 020. MEDICATION MANAGEMENT MARKET OVERVIEW BY END USERS
FIGURE 021. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 022. PHARMACIES MARKET OVERVIEW (2016-2028)
FIGURE 023. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 024. NORTH AMERICA MEDICATION MANAGEMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. EUROPE MEDICATION MANAGEMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. ASIA PACIFIC MEDICATION MANAGEMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. MIDDLE EAST & AFRICA MEDICATION MANAGEMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. SOUTH AMERICA MEDICATION MANAGEMENT MARKET OVERVIEW BY COUNTRY (2016-2028)